Literature DB >> 2522047

Differential secretion of tumor necrosis factor-alpha and granulocyte/macrophage colony-stimulating factors but not interferon-gamma from CD4+ compared to CD8+ human T cell clones.

G Pawelec1, K Schaudt, A Rehbein, F W Busch.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is a pleiotropic lymphokine which may have important regulatory effects on immune responses. It is shown here that eight alloreactive CD4+ T cell clones (TCC) secreted significant amounts of TNF-alpha after stimulation with either specific alloantigen or 12-O-tetradecanoylphorbol 13-acetate together with the calcium ionophore ionomycin (up to 50 ng/ml/24 h/10(6) cells) whereas CD8+ TCC failed to do so (max. 2 ng/ml/24 h/10(6) cells). The CD8+ TCC also secreted markedly less granulocyte/macrophage colony-stimulating factor than the CD4+ cells. However, this was not indicative of a general decrease of lymphokine production by CD8+ cells because CD4+ and CD8+ TCC both secreted similar amounts of interferon-gamma. These results show that regulatory CD4+ lymphocytes can produce large amounts of TNF-alpha, whereas CD8+ effector cells cannot do so.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522047     DOI: 10.1002/eji.1830190132

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells.

Authors:  C Jochum; R Voth; S Rossol; K H Meyer zum Büschenfelde; G Hess; H Will; H C Schröder; R Steffen; W E Müller
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

4.  Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation.

Authors:  C Canetti; J S Silva; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  A novel subset of helper T cells promotes immune responses by secreting GM-CSF.

Authors:  J Zhang; A I Roberts; C Liu; G Ren; G Xu; L Zhang; S Devadas; Yufang Shi
Journal:  Cell Death Differ       Date:  2013-09-27       Impact factor: 15.828

6.  Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes.

Authors:  W Held; H R MacDonald; I L Weissman; M W Hess; C Mueller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Production of interferon-gamma and tumour necrosis factor-alpha by human T-cell clones expressing different forms of the gamma delta receptor.

Authors:  S E Christmas; A Meager
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

8.  Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.

Authors:  R Karttunen; H M Surcel; G Andersson; H P Ekre; E Herva
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

9.  Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.

Authors:  S S Hom; S A Rosenberg; S L Topalian
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

10.  Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice.

Authors:  A P Taylor; H W Murray
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.